Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.7 |
mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.7 |
mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.023 | 0.7 |
mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |